A comparative study of PCS and PAM50 prostate cancer classification schemes.
Junhee YoonMinhyung KimEdwin M PosadasStephen J FreedlandYang LiuElai DavicioniRobert B DenBruce J TrockR Jeffrey KarnesEric E KleinMichael R FreemanSungyong YouPublished in: Prostate cancer and prostatic diseases (2021)
The PCS and PAM50 classification systems are similar in terms of molecular profiles and clinical outcomes. However, the PCS system exhibits greater separation in multiple clinical outcomes and provides better separation of prostate luminal and basal characteristics.